Zicix (OTCMKTS:ZICXD) vs. Solventum (NYSE:SOLV) Head-To-Head Survey

Solventum (NYSE:SOLV) and Zicix (OTCMKTS:ZICXD) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Earnings & Valuation

This table compares Solventum and Zicix”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.25 billion	1.81	$478.00 million	$8.68	9.92
Zicix	N/A	N/A	N/A	($100.14)	-0.03

Solventum has higher revenue and earnings than Zicix. Zicix is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Solventum has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500. Comparatively, Zicix has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Solventum and Zicix, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1	8	5	0	2.29
Zicix	0	0	0	0	0.00

Solventum currently has a consensus target price of $88.64, suggesting a potential upside of 2.92%. Given Solventum’s stronger consensus rating and higher possible upside, research analysts plainly believe Solventum is more favorable than Zicix.

Profitability

This table compares Solventum and Zicix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Solventum	18.13%	28.01%	7.17%
Zicix	N/A	N/A	N/A

Summary

Solventum beats Zicix on 9 of the 10 factors compared between the two stocks.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

About Zicix

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.